Dec. 3 Company Quick Takes: Brii adds neuroscience focus; plus Immunomedics, Hanmi-Rapt, Luye-Boan and Cara

Brii steps into neuroscience
Cross-border biotech Brii Biosciences said it will begin developing neuroscience programs as its second therapeutic area of interest, adding to its original focus on infectious diseases. The Beijing, China, and Durham, N.C.-based company has hired John Kraus

Read the full 400 word article

How to gain access

Continue reading with a
two-week free trial.